Method for detecting mutations and/or polymorphisms

• US 7,638,280 B2
• Filed: 12/22/2006
• Issued: 12/29/2009
• Est. Priority Date: 11/08/1999
• Status: Expired due to Fees

• Current Assignee: Eiken Kagaku Kabushiki Kaisha
• Original Assignee: Eiken Kagaku Kabushiki Kaisha
• Inventors: Notomi, Tsugunori, Kanda, Hidetoshi, Nagamine, Kentaro, Yonekawa, Toshihiro
• Primary Examiner(s): CALAMITA, HEATHER
• Application Number:
  US11/615,742
• Publication Number:
  US 20070238113A1
• Time in Patent Office: 1,103 Days
• Field of Search: None
• US Class Current: 435/6.12
• CPC Class Codes: C12Q 1/6827 for detection of mutation or polymorphism
• CPC Class Codes: Y02A 50/30 Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

The method of the present invention is based on a method wherein a nucleic acid is synthesized utilizing the hybridized 3′-end, which is synthesized by complementary strand synthesis, on a specific region of a target nucleotide sequence existing as the nucleotide sequence of the same strand as the origin for the next round of complementary strand synthesis. The hybridization to a specific region, which region is searched for mutations and polymorphisms, is repeatedly carried out according to the present invention. Thus, mutations and polymorphisms in a target nucleotide sequence are exactly copied to the reaction products.

Claims

1. A kit for detecting a mutation and/or polymorphism of a specific region in a target nucleotide sequence comprising the following elements (i)-(vi), wherein a nucleotide sequence arranged on at least one of the 5′

-ends of a second and first primer contains a nucleotide sequence complementary to the predicted nucleotide sequence of said specific region or the complementary strand thereof, further wherein the complementary strand, that is synthesized using the nucleotide sequence arranged on this 5′

-end as the template and functions as the origin of complementary strand synthesis by annealing to the specific region or the complementary strand thereof, inhibits the complementary strand synthesis when the nucleotide sequence that contains the specific region is not a predicted one;

i) one or more second primers, wherein the 3′

-end of the second primer anneals to the 3′

-side of the specific region of one of said target nucleotide sequence strands, and the 5′

-end of the second primer includes a nucleotide sequence complementary to the predicted nucleotide sequence that constitutes a region on the product of the complementary strand synthesis reaction that uses this primer as the origin, said one or more second primers being selected from the group consisting of the nucleic acid molecule consisting of SEQ ID NO;

10 and the nucleic acid molecule consisting of SEQ ID NO;

12;

ii) one or more first primers, wherein the 3′

-end of the first primer anneals to the 3′

-side of the specific region of the other said target nucleotide sequence strand, and the 5′

-end of the first primer includes a nucleotide sequence complementary to the predicted nucleotide sequence that contains a region on the product of the complementary strand synthesis reaction that uses the primer as the origin, said one or more first primers being selected from the group consisting of the nucleic acid molecule consisting of SEQ ID NO;

11 and the nucleic acid molecule consisting of SEQ ID NO;

13;

iii) a third primer that serves as the origin of the complementary strand synthesis by annealing to the 3′

-side of the first primer annealing region in the template, said third primer consisting of the nucleotide sequence of SEQ ID NO;

2; and

iv) a fourth primer that serves as the origin of the complementary strand synthesis by annealing to the 3′

-side of the second primer annealing region in the template, said fourth primer consisting of the nucleotide sequence of SEQ ID NO;

4;

v) a DNA polymerase catalyzing complementary strand synthesis which includes a strand displacement; and

vi) nucleotide substrates;

wherein the target nucleotide sequence is part of the human CYP2C19 gene; and

whereby the products of complementary strand synthesis of the first and second primers will be capable of self-annealing between the portion thereof corresponding to the 5′

-end of the primer and the portion thereof that contains the nucleotide sequence complementary to the predicted nucleotide sequence, thereby forming a stem-loop structure, when the specific region contains the predicted nucleotide sequence.

2. A kit for detecting a mutation and/or polymorphism in the human CYP2C19 gene, comprising the following elements (i)-(vi):

i) a primer consisting of the nucleotide sequence of SEQ ID No;

10,

ii) a primer consisting of the nucleotide sequence of SEQ ID No;

11,

iii) a primer consisting of the nucleotide sequence of SEQ ID No;

4,

iv) a primer consisting of the nucleotide sequence of SEQ ID No;

2,

v) a DNA polymerase catalyzing complementary strand synthesis which includes a strand displacement; and

vi) nucleotide substrates.

3. The kit of claim 2 additionally comprising one or both of the following elements vii) and viii):

vii) a primer consisting of the nucleotide sequence of SEQ ID No;

14, and

viii) a primer consisting of the nucleotide sequence of SEQ ID No;

15.

4. The kit of claim 3 additionally comprising instructions for using the kit components to detect mutations and/or polymorphisms in the human CYP2C19 gene.

5. The kit of claim 2 additionally comprising instructions for using the kit components to detect mutations and/or polymorphisms in the human CYP2C19 gene.

6. A kit for detecting a mutation and/or polymorphism in the human CYP2C 19 gene, comprising the following elements (i)-(vi):

i) a primer consisting of the nucleotide sequence of SEQ ID No;

12,

ii) a primer consisting of the nucleotide sequence of SEQ ID No;

13,

iii) a primer consisting of the nucleotide sequence of SEQ ID No;

4,

iv) a primer consisting of the nucleotide sequence of SEQ ID No;

2,

v) a DNA polymerase catalyzing complementary strand synthesis which includes a strand displacement; and

vi) nucleotide substrates.

7. The kit of claim 6 additionally comprising one or both of the following elements vii) and viii):

vii) a primer consisting of the nucleotide sequence of SEQ ID No;

14, and

viii) a primer consisting of the nucleotide sequence of SEQ ID No;

15.

8. The kit of claim 7 additionally comprising instructions for using the kit components to detect mutations and/or polymorphisms in the human CYP2C19 gene.

9. The kit of claim 6 additionally comprising instructions for using the kit components to detect mutations and/or polymorphisms in the human CYP2C19 gene.

10. A kit for detecting a mutation and/or polymorphism in the human CYP2C19 gene, comprising the following elements (i)-(viii):

i) a primer consisting of the nucleotide sequence of SEQ ID No;

10,

ii) a primer consisting of the nucleotide sequence of SEQ ID No;

11,

iii) a primer consisting of the nucleotide sequence of SEQ ID No;

12,

iv) a primer consisting of the nucleotide sequence of SEQ ID No;

13,

v) a primer consisting of the nucleotide sequence of SEQ ID No;

4, and

vi) a primer consisting of the nucleotide sequence of SEQ ID No;

2,

vii) a DNA polymerase catalyzing complementary strand synthesis which includes a strand displacement; and

viii) nucleotide substrates.

11. The kit of claim 10 additionally comprising one of or both of the following elements ix) and x):

ix) a primer consisting of the nucleotide sequence of SEQ ID No;

14, and

x) a primer consisting of the nucleotide sequence of SEQ ID No;

15.

12. The kit of claim 11 additionally comprising instructions for using the kit components to detect mutations and/or polymorphisms in the human CYP2C19 gene.

13. The kit of claim 10 additionally comprising instructions for using the kit components to detect mutations and/or polymorphisms in the human CYP2C19 gene.